MDI and DPI Drug Products
...The guidance sets forth information that should be provided to ensure continuing drug.....manufacturing, processing, packaging, controls, stability testing, or labeling operations.....establish a set of criteria to which a drug substance or drug product should conform using..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=100)

þÿ
...18 The applicant and/or drug product manufacturer must establish the reliability of the.....should explain the scientific reasons why a stability indicating procedure is not viable.....associated acceptance criteria depend on the route of administration of the drug product and..
http://www.fda.gov/cder/guidance/3969DFT.pdf (score=81)

þÿ
...18 The applicant and/or drug product manufacturer must establish the reliability of the.....should explain the scientific reasons why a stability indicating procedure is not viable.....associated acceptance criteria depend on the route of administration of the drug product and..
http://www.fda.gov/OHRMS/DOCKETS/98fr/2003d-0571-gdl0001.pdf (score=79)

Guidance for Industry - Content and Format of Chemistry, Manufacturing and...
...If the drug product is frozen, data supporting the stability of the product through a stated.....This section should contain information on the final drug product including all drug substances.....the evidence derived from validation studies which assures that product identity, purity, potency, and stability is preserved for..
http://www.fda.gov/cber/gdlns/cmcvacc.htm (score=68)

stability guidance -draft
...Significant change for a drug product at the accelerated stability condition and the.....this guidance to mean a batch of drug substance or drug product manufactured at the scale typically encountered.....satisfactory product stability, which may in turn include, but not be limited to, full long-term..
http://www.fda.gov/cder/guidance/1707dft.pdf (score=66)

PET Drug Products … Current Good Manufacturing Practice (CGMP)
...ensure that each batch of PET drug product meets its established acceptance criteria, 1201.....stability parameters include radiochemical identity and purity, appearance, pH, stabilizer.....or lot, of a PET drug typically consists of one multiple-dose vial containing the PET drug..
http://www.fda.gov/cder/guidance/4259dft.pdf (score=66)

Packaging
...It should provide an adequate seal, be compatible with the drug product, and not be a source of.....This information should include the proposed market package for the product and the relevant stability and.....Samples of a drug that are selected for stability studies should be packaged in the container/clsoure system in which..
http://www.fda.gov/cder/guidance/package.htm (score=64)

PET Drug Products - Current Good Manufacturing Practice (CGMP)
...Appropriate parameters should be evaluated to establish and document the stability of a PET drug product under.....Stability testing of the PET drug product should be performed at the highest radioactive concentration, and the whole batch.....Critical activities in the production and testing of a PET drug product that expose the PET drug product or the sterile surface..
http://www.fda.gov/cder/guidance/4259dft.htm (score=62)

Guidance for Industry
...ensuring that the drug product provided to the patient has the appropriate identity, strength.....provided that they meet appropriate standards or specifications as demonstrated by.....if the condition of the drug product, as a result of storage or shipping, casts doubt on the..
http://www.fda.gov/OHRMS/DOCKETS/98fr/03d-0165-gdl0001.pdf (score=62)

6003dft.doc
...changes and that no adverse impact on the quality, safety, or efficacy of the drug product.....therefore, real-time concurrent stability studies on the product potentially affected by.....contractual arrangement to produce the intermediates, drug substance, or drug product on..
http://www.fda.gov/cder/guidance/6003dft.pdf (score=60)

Validation of Chromatographic Methods
...Solution stability of the drug substance or drug product after preparation..according to the test method should be evaluated.....with the regulatory impurities method relating to release and stability of..both drug substance and drug product.Detection limit is.....throughout the life of the drug product. Data that are generated for acceptance,release..
http://www.fda.gov/cder/guidance/cmc3.pdf (score=59)

Draft Guidance: ICH Q5E: Comparability of Biotechnological/Biological...
...The tests and analytical procedures chosen to define drug substance or drug product specifications alone are.....Generally, therefore, real-time concurrent stability studies on the product potentially.....Therefore, it might be appropriate to collect data on the drug product to support the..
http://www.fda.gov/cber/gdlns/ichcompbio.htm (score=58)

International Conference on Harmonisation; Draft Guidance on Q5E...
...changes and that no adverse impact on the quality, safety, or efficacy of the drug product.....therefore, real-time concurrent stability studies on the product potentially affected by.....contractual arrangement to produce the intermediates, drug substance, or drug product on..
http://www.fda.gov/cber/gdlns/ichcompbio.pdf (score=56)

HUMAN DRUG CGMP NOTES June 1966
...used in the delivery of a medical drug product is considered an integral part of the drug.....Where stability testing reveals that the BPC is stable for the intended period of use, or.....Information on a failure of a batch of new drug product to meet a specification is required to..
http://www.fda.gov/cder/hdn/hdn696.htm (score=55)

Microsoft Word - 5320.1.doc
...Description of the Composition of the Drug Product..Description of the drug product composition.....2 Post-Approval Stability Protocol and Stability Commitment.. Analytical procedures and testing schedule for.....References to the corresponding drug product..sections of the CTD-Q and a reference to the ICH..
http://www.fda.gov/cder/mapp/5320.1.pdf (score=54)

Q1B Photostability Testing of New Drug Substances and Products
...The extent of drug product testing should be established by assessing whether or not acceptable.....The ICH Harmonized Tripartite Guideline on Stability Testing of New Drug Substances and.....Testing should progress until the results demonstrate that the drug product is adequately..
http://www.fda.gov/cder/guidance/1318.htm (score=53)

/a//content.14388
...Mixing, granulating, milling, molding, of components, drug product containers, formulating.....whether they use terminal sterilization, three initial batches in the stability.. Sampling.....Therefore, under the Federal Food, all established standards, specifications, Drug, and..
http://www.fda.gov/cder/dmpq/fr5396.pdf (score=53)

Content and Format of INDs for Phase 1 Studies of Drugs, Inclu
...used to monitor the stability of the drug product packaged in..the proposed container/closure system and storage.....Food and Drug Administration, Center for Drug Evaluation and Research,"IND Process and.....manufacturing differences between the drug product proposed for..clinical use and the drug..
http://www.fda.gov/cder/guidance/clin2.pdf (score=52)

IND content and format for Phase 1 studies
...As clinical development of a drug product proceeds,sponsors should discuss the manufacturing.....methods used to monitor the stability of the drug..product packaged in the proposed.....Information to support the stability of the drug..substance during the toxicologic studies..
http://www.fda.gov/cder/guidance/phase1.pdf (score=52)

Microsoft Word - 5020.1.doc
...Description of the Composition of the Drug Product..Description of the drug product composition.....2 Post-Approval Stability Protocol and Stability Commitment.. Analytical procedures and testing schedule for.....References to the corresponding drug product..sections of the CTD-Q and a reference to the ICH..
http://www.fda.gov/cder/mapp/5020.1.pdf (score=51)

Las Vegas Injury Lawyer